AGL · agilon health, inc. · Executive Compensation
$89.71
-0.58 (-0.64%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.51B
Shares
16.79M
Volume · Oct 23
189.62K
Avg daily vol (3M)
264.17K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Steven Sell | Former Chief Executive Officer and President | $7,278,387 |
| Jeffrey Schwaneke | Chief Financial Officer and Interim Co-Principal Executive Officer | $5,610,878 |
| Benjamin Shaker | Chief Markets Officer and Interim Co-Principal Executive Officer | $5,357,548 |
| Denise Zamore | Chief Legal Officer and Corporate Secretary | $3,123,418 |
| Girish Venkatachaliah | Chief Technology Officer | $2,056,086 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jeffrey Schwaneke | Chief Financial Officer and Interim Co-Principal Executive Officer | $7,136,122 |
| Steven J. Sell | Chief Executive Officer and President | $5,416,043 |
| Steven Sell | Former Chief Executive Officer and President | $5,416,043 |
| Veeral Desai | Former Chief Strategy and Development Officer | $4,408,328 |
| Jeffrey A. Schwaneke | Chief Financial Officer Benjamin Shaker Chief Markets Officer 2022 | $4,102,777 |
| Benjamin Shaker | Chief Markets Officer and Interim Co-Principal Executive Officer | $4,102,777 |
| Girish Venkatachaliah | Chief Technology Officer | $2,560,893 |
| Timothy Bensley | Former Chief Financial Officer | $373,973 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Steven Sell | Former Chief Executive Officer and President | $5,267,036 |
| Steven J. Sell | Chief Executive Officer and President | $5,267,036 |
| Veeral Desai | Former Chief Strategy and Development Officer | $3,404,882 |
| Jeffrey A. Schwaneke | Chief Financial Officer Benjamin Shaker Chief Markets Officer 2022 | $2,930,218 |
| Jeffrey Schwaneke | CFO | $2,930,218 |
| Benjamin Shaker | Chief Markets Officer and Interim Co-Principal Executive Officer | $2,930,218 |
| Girish Venkatachaliah | Chief Technology Officer | $2,880,218 |
| Timothy Bensley | Former Chief Financial Officer | $1,750,039 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Steven J. Sell | Chief Executive Officer and President | $5,789,157 |
| Benjamin Shaker | Chief Markets Officer | $2,590,536 |
| Veeral Desai | Former Chief Strategy and Development Officer | $2,159,304 |
| Timothy Bensley | Former Chief Financial Officer | $2,081,337 |
| Girish Venkatachaliah | Chief Technology Officer | $1,646,767 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Benjamin Shaker | Chief Markets Officer | $7,957,897 |
| Tim Bensley | Chief Financial Officer | $5,821,031 |
| Timothy Bensley | Chief Financial Officer | $5,821,031 |
| Girish Venkatachaliah | Chief Technology Officer | $3,283,039 |
| Veeral Desai | Chief Strategy and Development Officer | $1,768,231 |
| Steven J. Sell | Chief Executive Officer and President | $1,256,250 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Steven J. Sell | Chief Executive Officer and President | $6,038,585 |
| Theodore Halkias | Chief Business Officer | $697,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Girish Venkatachaliah | Chief Technology Officer | Terminated | 2026-07-22 |
| Tim O'Rourke | Class III director | Appointed | 2026-04-27 |
| Tim O'Rourke | Chief Executive Officer and President | Appointed | 2026-04-27 |
| Ronald A. Williams | Executive Chairman | Appointed | 2025-08-04 |
| Steven J. Sell | Board of Directors | Resigned | 2025-08-04 |
| Steven J. Sell | Chief Executive Officer and President | Resigned | 2025-08-04 |
| Jeff Schwaneke | Board of Directors | Resigned | 2024-06-05 |
| Timothy Bensley | Chief Financial Officer | Retired | 2024-06-05 |
| Jeff Schwaneke | Chief Financial Officer and Executive Vice President | Appointed | 2024-06-05 |
| Karthik Rao, M.D. | Interim Chief Medical Officer | Appointed | 2024-02-08 |
| Timothy Gertsch | Chief Accounting Officer | Appointed | 2023-08-16 |
| Silvana Battaglia | independent Class I Director | Appointed | 2023-06-26 |
| Derek L. Strum | Director | Resigned | 2023-06-26 |
| Clay Richards | Director | Resigned | 2023-06-26 |
| Richard Schnall | Director | Resigned | 2023-06-26 |
| Diana L. McKenzie | Class II director | Appointed | 2023-02-22 |
| Dr. Michelle A. Gourdine | Board of Directors | Resigned | 2022-12-20 |
| Priscilla Kasenchak | Chief Accounting Officer | Appointed | 2022-09-30 |
| Jeffrey A. Schwaneke | Class I director | Appointed | 2022-08-10 |
| Michael Smith | board of directors | Resigned | 2022-08-10 |
Leadership
- Benjamin Shaker CEO
- Jeffrey A. Schwaneke CEO, Board Member
- Steven Sell CEO
- Tim O'Rourke CEO, Board Member
- Ronald A. Williams Chairman
- Jeffrey Schwaneke CFO
- Priscilla Kasenchak Chief Accounting Officer
- Timothy Gertsch Chief Accounting Officer
- Diana L. McKenzie Board Member
- Diana McKenzie Board Member
- Karen McLoughlin Board Member
- Ronald Williams Board Member
Key facts
CIK
1831097
CUSIP
00857U206
13F (30d)
23 filings
23 filers
Visit website
Investor relations